• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Stroke/CVA (1770); Congestive Heart Failure (1783); Hematoma (1884); Hemorrhage/Bleeding (1888); Muscle Spasm(s) (1966); Myocardial Infarction (1969); Occlusion (1984); Perforation (2001); Renal Failure (2041); Stenosis (2263); Pseudoaneurysm (2605)
Event Date 09/30/2017
Event Type  Injury  
Manufacturer Narrative
Journal name: international heart journal title of article: three-year major clinical outcomes of angiography-guided single stenting technique in non-complex left main coronary artery diseases literature reference: doi:10.1536/ihj.17-115 received for publication february 24, 2017.Revised and accepted june 5, 2017.Released in advance online on j-stage september 30, 2017.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A 239 patients were enrolled to the study and divided into 2 sub-groups - angiography-guided pci and ivus-guided pci.The study population included 196 eligible patients with non-complex lmca disease treated with the single stenting technique using des.Resolute zotarolimus-eluting stents were implanted in the rca, ramus, lmca, lad and lcx during the study.Patients were administered unfractionated heparin pre-operatively.Peri-procedural complications reported in this study include: hematoma, pseudo-aneurysm, acute renal failure, congestive heart failure, stroke, dissection, perforation, occlusion and spasm.The cumulative incidence of various individual and composite clinical outcomes during the 3-year clinical follow-up was compared between the two groups.Clinical outcomes included death, myocardial infarction, revascularization, cerebral haemorrhage, septic shock and major adverse cardiac events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7111874
MDR Text Key94630469
Report Number9612164-2017-01897
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/15/2017
Initial Date FDA Received12/13/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age63 YR
-
-